Alphabet Inc. (NASDAQ: GOOGL) released its most recent quarterly results after markets closed Monday. The company reported $13.33 in earnings per share (EPS) on $31.15 billion in revenue, compared with consensus estimates that called for $9.31 in EPS on $30.31 billion in revenue. The same period from last year had $7.73 in EPS on $24.75 billion in revenue.
Traffic acquisition costs (TAC) to Google Network Members and distribution partners totaled $6.29 billion at the end of the quarter, up from $4.63 billion in the same period last year. Total TAC as a percent of Google advertising revenues was 24% for the quarter, up from 22%.
Paid clicks on Google properties increased 59% year over year, and 8% quarter over quarter. The cost-per-click on Google properties decreased 19% year over year, and 7% quarter over quarter.
In terms of its segments Alphabet reported:
Google advertising revenues totaled $26.64 billion, up 24.4% year over year. Google other revenues totaled $4.35 billion, up 35.8%. Other Bets revenues totaled $150 million, up 13.6%.
On the books, cash, cash equivalents, and marketable securities totaled $102.89 billion at the end of the quarter, versus $101.87 billion at the end of the previous fiscal year.
Best High Tech Stocks To Invest In Right Now: iShares Core S&P Mid-Cap (IJH)
- [By WWW.GURUFOCUS.COM]
For the details of Lubar & Co., Inc’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Lubar+%26+Co.%2C+Inc
These are the top 5 holdings of Lubar & Co., IncEnLink Midstream LLC (ENLC) – 1,882,007 shares, 37.97% of the total portfolio. Shares added by 0.40%Hallador Energy Co (HNRG) – 2,788,685 shares, 23.23% of the total portfolio. Vanguard Value ETF – DNQ (VTV) – 77,126 shares, 7.65% of the total portfolio. iShares Core S&P Mid-Cap (IJH) – 38,400 shares, 6.84% of the total portfolio. New PositionVanguard Mid-Cap Value ETF – DNQ (VOE) – 61,550 shares, 6.52% of the tota
Best High Tech Stocks To Invest In Right Now: Franklin Covey Company(FC)
- [By Monica Gerson]
Darden Restaurants, Inc. (NYSE: DRI) is estimated to report its quarterly earnings at $1.08 per share on revenue of $1.81 billion.
ConAgra Foods Inc (NYSE: CAG) is expected to report its quarterly earnings at $0.52 per share on revenue of $2.89 billion.
Paychex, Inc. (NASDAQ: PAYX) is projected to report its quarterly earnings at $0.49 per share on revenue of $751.52 million.
Micron Technology, Inc. (NASDAQ: MU) is expected to post a quarterly loss at $0.09 per share on revenue of $2.95 billion.
McCormick & Company, Incorporated (NYSE: MKC) is estimated to report its quarterly earnings at $0.74 per share on revenue of $1.06 billion.
Constellation Brands, Inc. (NYSE: STZ) is expected to report its quarterly earnings at $1.51 per share.
Schnitzer Steel Industries, Inc. (NASDAQ: SCHN) is estimated to report its quarterly earnings at $0.18 per share on revenue of $356.41 million.
Franklin Covey Co. (NYSE: FC) is expected to post its quarterly earnings at $0.08 per share on revenue of $49.89 million.
Lindsay Corporation (NYSE: LNN) is projected to report its quarterly earnings at $0.99 per share on revenue of $148.43 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
Best High Tech Stocks To Invest In Right Now: International Game Technology(IGT)
- [By Dan Caplinger]
Thursday was another strong day on Wall Street, with major benchmarks posting gains across the board. The S&P 500 reached another all-time high on strength from an upbeat view of the economy and good earnings results from major companies in the retail sector. Although energy prices sagged, investors seemed to focus on the cost savings that consumers would enjoy from cheaper gasoline rather than the profit hit that major oil and natural gas companies might suffer. Still, not every stock participated in the rally, and International Game Technology (NYSE:IGT), Genesco (NYSE:GCO), and Ensco (NYSE:ESV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
- [By Michael Flannelly]
Analysts at Sterne Agee noted on Monday that International Game Technology’s (IGT) fiscal 2014 growth is stronger than it appears. As such, the analysts raised the price target on the casino gaming equipment manufacturer.
The analysts maintain a “Buy” rating on IGT and now see shares reaching $25, up from the previous target of $23. This new price target suggests a 23% upside to the stock’s Friday closing price of $20.32.
“Excluding FY13 Canadian VLT sales, which do not recur in FY14, consensus FY14 EPS growth is ~14% versus ‘in-print’ consensus EPS growth of ~4%,” Sterne Agee analyst David Bain said. “We believe IGT’s peer-low stock valuation is partly driven by a misinterpretation of forward growth using ‘in-print’ FY14 EPS projections.”
Futhermore, the firm raised IGT’s fourth quarter EPS estimates from 33 cents to 34 cents.
IGT shares were inactive during pre-market trading on Monday. The stock is up 43.4% year-to-date.
- [By Dan Caplinger]
Yet even though the overall market remained resilient in the face of some threats to positive sentiment among investors, some stocks posted substantial losses. Stratasys (NASDAQ:SSYS), International Game Technology (NYSE:IGT), and Momo (NASDAQ:MOMO) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.
Best High Tech Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)
- [By ]
Other recent false “tells” of “unusual call activity” have included Lowe’s (LOW) , Valeant Pharmaceuticals (VRX) , Walmart (WMT) and Walt Disney Co. (DIS) . All of these stocks tanked within one or two weeks of the unusual call trading.
- [By Chris Lange]
Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. Along with this success, Valeant reported the sale of a couple of its business segments, bringing in a sizable amount of cash.
- [By Ben Levisohn]
Today is not a good day for Valeant Pharmaceuticals International (VRX). After an announcement last night that it was hiring a sales force to push Salix products suggested that the unit might not be sold, reports emerged that suggest that a Salix sale was not going to happen. And now letters from the SEC have emerged that question Valeant’s use of non-GAAP measures. Wells Fargo’s David Maris and team explain the significance:
New SEC correspondence reveals potential problems with Valeant’s tax accounting and use of adjusted earnings metrics. In a series of letters made available by the SEC today, it appears the SEC has been questioning Valeant in regards to its tax reporting and disclosures, among other items. Recall that in our initiation of coverage report published in February 2016 we wrote extensively about potential problems arising from Valeant’s tax reporting, as well as its use of valuation allowances. It also appears from the correspondence that in response to concerns highlighted by the SEC, Valeant is re-assessing its current non-GAAP reporting and disclosures and is likely to present new measures and disclosures with its 2017 guidance and 4Q16 results, including a potential new adjusted net income measure. The correspondence between the SEC and Valeant can be found here: bit.ly/VUP1130 and here: bit.ly/VCOR1130
In additional news we consider disappointing, the Wall Street Journal is reporting that Valeant’s rumored talks to sell its Salix business to Takeda have broken down over disagreement in price. Separately, following yesterday’s market close, Valeant issued a press release announcing its initiation of a primary care salesforce for its Xifaxan and Relistor products. Valeant stated that the associated cost would not impact 2016 guidance; however, there was no indication of the potential impact to 2017.
Shares of Valeant Pharmaceuticals International have dropped 9% to $15.61 at
Best High Tech Stocks To Invest In Right Now: Syngenta AG(SYT)
- [By WWW.THESTREET.COM]
Syngenta AG (SYT) CEO Erik Fyrwald said Wednesday that he was “entirely confident” the company’s $43 billion takeover by China National Chemical Corp. would close in the second quarter of this year and dismissed suggestions it would be disrupted by a third party.
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.